Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piano Level Laser Therapy vs EGF in Myogenic TMD
NCT06044974Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of epidermal growth factor in temporomandibular joint disorders (TMD), sponsored by Alexandria University. Started Jan 2023; status: completed.
02
Drugs
epidermal growth factor
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT06044974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06044974.